Get startedLog in
    Picture of ALX Oncology Holdings logo

    ALXO — ALX Oncology Holdings News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeSmall CapMomentum Trap
    All News

    Brief: Alx Oncology Announces First Patient Dosed In Aspen-06

    Picture of ALX Oncology Holdings logoALX Oncology Holdings
    02/03/2022 12:35
    March 2 (Reuters) - ALX Oncology Holdings Inc  ALXO.O :
    * ALX ONCOLOGY ANNOUNCES FIRST PATIENT DOSED IN ASPEN-06, A
PHASE
2/3 STUDY OF EVORPACEPT FOR THE TREATMENT OF PATIENTS WITH
ADVANCED GASTRIC OR GASTROESOPHAGEAL JUNCTION CANCER

Source text for Eikon:  ID:nGNX6q0TtJ 
Further company coverage:  ALXO.O 

 ((reuters.briefs@thomsonreuters.com;))

    Recent news on ALX Oncology Holdings

    See all news